Survival of long nerve allografts following donor antigen pretreatment: A pilot study

Journal of Reconstructive Microsurgery

Volumn 22, Issue 6, 2006, Pages 443-449

  Tung, Thomas H ^a   Doolabh, Vaishali B ^a   Mackinnon, Susan B ^a,b   Mohanakumar, T ^a   Hicks, Marshall E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Plastic and Reconstructive Surgery   (United States)

Author keywords

Antigen pretreatment; Donor specific immunosuppression; Long nerve allograft; UV B irradiation

Indexed keywords

ALLOANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT SURVIVAL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MORPHOMETRICS; NERVE GRAFT; NERVE REGENERATION; NERVE TRANSPLANTATION; NONHUMAN; PILOT STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SWINE; TRANSPLANTATION TOLERANCE; ULTRAVIOLET B RADIATION;

ANIMALS; GRAFT SURVIVAL; IMMUNOSUPPRESSION; ISOANTIGENS; LYMPHOCYTE CULTURE TEST, MIXED; NERVE REGENERATION; PERIPHERAL NERVES; PILOT PROJECTS; SWINE; SWINE, MINIATURE; TRANSPLANTATION TOLERANCE; ULTRAVIOLET RAYS;

EID: 33747348711     PISSN: 0743684X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-947699     Document Type: Article

References (31)

1. Mackinnon SE, Hudson AR. Clinical application of peripheral nerve transplantation. Plast Reconstr Surg 1992;90:696-699
2. Mackinnon SE. Nerve allotransplantation following severe tibial nerve injury-a case report. Neurosurg 1996;84:671-676
3. Brenner MJ, Tung TH, Jensen JN, et al. The spectrum of complications of immunosuppression: is the time right for hand transplantation? J Bone Joint Surg Am 2002;84:1861-1870
4. Qian JH, Kokudo S, Sato S, et al. Tolerance induction of alloreactivity by portal venous inoculation with allogeneic cells followed by the injection of cyclophosphamide. I. Specific suppression of alloreactive cytotoxic and delayed-type hypersensitivity responses as well as allograft rejection. Transplantation 1987;43:538-543
5. Hamashima T, Yoshimura N, Matsui S, et al. The effects of perioperative portal venous inoculation with donor lymphocytes on renal allograft survival in the rat. Tranplantation 1990;49:171-175
6. Kamei T, Callery MP, Rye MW. Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolongs rat cardiac allograft survival. Surgery 1990;108:415-422
7. Yu S, Nakafusa Y, Flye MW. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance. Surgery 1994;116:229-234; discussion 234-235
8. Genden EM, Mackinnon SE, Yu S, et al. Induction of donor specific tolerance to rat nerve allografts with portal venous donor alloantigen and anti-ICAM-1/LFA-1 monoclonal antibodies. Surgery 1998;124:448-456
9. Atchabahian A, Genden EM, Mackinnon SE, et al. Regeneration through long nerve grafts in the swine model. Microsurgery. 1998;18:379-382
10. Ide C, Tohyama K, Tajima K, et al. Long acellular nerve transplants for allogeneic grafting and the effects of basic fibroblast growth factor on the growth of regenerating axons in dogs: a preliminary report. Exp Neurol 1998;154:99-112
11. Matsuyama T, Midha R, Mackinnon SE, et al. Long nerve allografts in sheep with Cyclosporin A immunosuppression. J Reconstr Microsurg 2000;16:219-225
12. Singh R, Vriesendorp HM, Mechelse K, et al. Cadaver nerve allografts in dogs. Biomedicine 1981;35:67-70
13. Singh R, Mechelse K, Stefanko S. Role of tissue typing on preserved nerve allografts in dogs. J Neurol Neurosurg Psychiatry 1977;40:865-871
14. Singh R, Vriesendorp HM, Mechelse K, et al. Nerve allografts and histocompatibility in dogs. J Neurosurgery 1977;47:737-743
15. Singh R. Experience with allografts in the surgery of peripheral nerves (experimental study). Acta Neurochir (Wien) 1976;34:195-201
16. Tajima K, Tohyama K, Ide C, et al. Regeneration through nerve allografts in the cynomolgus monkey (Macaca fascicularis). J Bone Joint Surg Am 1991;73:172-185
17. Bain JR, Mackinnon SE, Hudson AR, et al. The peripheral nerve allograft in the primate immunosuppressed with cyclosporin A. Part 1: histologic and electrophysiologic assessment. Plast Reconstr Surg 1992;90:1036-1046
18. Callery MP, Kamei T, Flye MW. Kupffer cell blockade inhibits induction of tolerance by the portal venous route. Transplantation 1989;47:1092-1094
19. Callery MP, Kamei T, Flye MW. The anatomic site specificity of tolerance induction to alloantigen. Transplantation 1990;49:230-233
20. Kamei T, Callery MP, Flye MW. Kupffer cell blockade prevents induction of portal venous tolerance in rat cardiac allograft transplantation. J Surg Res 1990;48:393-396
21. Kripke ML. Ultraviolet radiation and immunology: something new under the sun-presidential address. Cancer Res 1994;54:6102-6105
22. Levin D, Gershon H. Interleukin production by neonatal spleen cells during and as a result of antigen presentation: the effect of ultraviolet light. Lymphokine Res 1989;8:185-201
23. Yu S, Tu Y, Flye MW. The shift of Th1/Th2 ratios induced by portal venous administration of UVB-treated donor spleen cells prolonged mouse cardiac allografts. Transplantation Proc 1997;29:1162
24. Opelz G, Sengar DP, Mickey MR, et al. Effect of blood transfusions on subsequent kidney transplants. Transplantation Proceedings 1973;5:253-259
25. Opelz G, Terasaki PI. Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med 1978;299:799-803
26. Anderson CB, Tyler JD, Sicard GA, et al. Pretreatment of renal allograft recipients with immunosuppression and donor-specific blood. Transplantation 1984;38:664-668
27. Glass NR, Miller DT, Sollinger HW, et al. A four-year experience with donor blood transfusion protocols for living donor renal transplantation. Tranplantation 1985;39:615-619
28. Salvatierra O Jr, Melzer J, Potter D, et al. A seven-year experience with donor-specific blood transfusions. Results and considerations for maximum efficacy. Transplantation 1985;40:654-659
29. Hadley GA, Anderson CB, Mohanakumar T. Selective loss of functional antidonor cytolytic T cell precursors following donor-specific blood transfusions in long-term renal allograft recipients. Tranplantation 1992;54:333-337
30. Grailer AP, Sollinger HW, Kawamura T, et al. Donor-specific cytotoxic T lymphocyte hyporesponsiveness following renal transplantation in patients pretreated with donor-specific transfusions. Transplantation 1991;51:320-324
31. Flye MW, Burton K, Mohanakumar T, et al. Donor specific transfusions have long term beneficial effects for human renal allografts. Transplantation 1995;60:1395-1401